Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
351 Results Found
Grand Junction Community Hospital | Colorado
Community Hospital is an
independent, nonprofit acute
care hospital that’s been
operating in Grand Junction, Colo., since 1946.
340B Drug Pricing Program
For more than 30 years, the 340B Drug Pricing Program has provided financial help to hospitals serving vulnerable communities to manage rising prescription drug costs.
Johnson County Hospital | Nebraska
Johnson County Hospital is an 18-bed critical access hospital based in Tecumseh, Nebraska.
AHA, others urge HRSA to extend timeline for comments and feedback on 340B pilot program
The AHA, joined by several other national groups representing 340B hospitals, Aug. 8 urged the Health Resources and Services Administration to extend the timeline for stakeholder comments, agency consideration and manufacturer rebate plan submissions for its 340B Rebate Model Pilot Program.
AHA 340B Advocacy Alliance Bulletin August 8, 2025
The AHA, joined by several other national groups representing 340B hospitals, today urged the Health Resources and Services Administration to extend the timeline for stakeholder comments, agency consideration, and manufacturer rebate plan submissions for its 340B Rebate Model Pilot Program.
AHA, Health Associations Comment on HRSA Notice of a 340B Rebate Model Pilot Program
AHA, health associations initial comment on the Health Resources and Services Administration’s (HRSA) notice of a 340B Rebate Model Pilot Program.
HRSA Issues Notice Establishing 340B Rebate Model Pilot Program
The Health Resources and Services Administration (HRSA) July 31 announced a 340B rebate model pilot program that will provide certain drugmakers the option to effectuate access to 340B discounted pricing for certain drugs under a rebate model.
340B Advocacy Alliance Bulletin - August 5, 2025
AHA Defends HHS Court Decision on 340B Rebate Model
AHA defends HHS decision to reject 340B rebate models by drug companies
The AHA today filed an amicus brief in the U.S.
AHA, Others Defend HHS Decision to Reject 340B Rebate Models by Drug Companies
ORAL ARGUMENT NOT YET SCHEDULEDNos. 25-5177, 25-5179, 25-5220, 25-5221, 25-5236